Should FDA have looked into TSA’s use of back-scatter devices?
Filed under: Healthcare Technology News, In this week's e-newsletter, Latest News & Views, Patient/Client Communication
A recent report indicates that the feds implemented controversial back-scatter X-rays throughout airports despite legitimate safety concerns from experts on radiation and public health issues. Read more
Obama takes action on growing drug shortage crisis
Filed under: Ethics, Fraud & Waste, Healthcare Finance, Hospital Management, In this week's e-newsletter, Latest News & Views
The nationwide shortage of key medications is finally getting some attention from the White House. Read more
New pill design could keep generics out of reach longer
Filed under: Health care/Treatment trends, Healthcare Finance, In this week's e-newsletter, Latest News & Views, Patient/Client Communication
Something as simple as adding a score mark to a pill could be enough to keep competition from generic pill manufacturers at bay. Read more
The scary truth about two common drugs
Filed under: EMR & EHR - Electronic Health Records, Health care/Treatment trends, Healthcare Technology News, In this week's e-newsletter, Latest News & Views
A potentially dangerous side effect of two commonly prescribed drugs was just uncovered — and the way it was found is just as interesting as the actual side effect. Read more
Key drug to prevent preemies to increase from $20/shot to $1,500
Filed under: Health care/Treatment trends, In this week's e-newsletter, Insurance, Latest News & Views, Patient/Client Communication
The FDA approved a commercial version of a progesterone shot used by women at risk for pre-term birth — but the approval actually makes the drug much harder to get for most patients. Read more
Feds to take over 3 Tylenol plants
Filed under: Healthcare Finance, Healthcare Legal & Compliance, In this week's e-newsletter, Latest News & Views
After a series of drug recalls and a criminal investigation, the FDA is taking over three manufacturing plants for the popular medication. Read more
FDA orders 500 medications off the market pending further review
Filed under: Healthcare Finance, Healthcare Legal & Compliance, In this week's e-newsletter, Latest News & Views
Roughly 500 prescription drugs have been ordered off the market by the FDA, which claims that the medications never had a proper federal review for safety and effectiveness. Read more
How far can you trust your pharma-rep doc?
Filed under: Communication, Ethics, Healthcare Human Resources and Staffing News, Healthcare Legal & Compliance, Special Report
A new investigation shows that doctors drug companies hire as speakers and advisers aren’t always the best and the brightest in their fields. Some of them are outright criminals. Read more
Are those common drugs still safe 20 years later?
Filed under: Ethics, Health care/Treatment trends, Healthcare Finance, Healthcare Technology News, Patient/Client Communication, Special Report
Drugs approved for chronic conditions can have major side effects that aren’t discovered until years or decades after they’re approved. Is there a better way to protect patients? Read more
Look-alike tubes kill patients regularly: Why is this still allowed?
Filed under: Ethics, Health care/Treatment trends, Healthcare Legal & Compliance, Healthcare Technology News, In this week's e-newsletter, Latest News & Views
Mistakes as simple — and avoidable — as confusing an IV with a feeding tube regularly injure and kill patients. And industry interests seem content to allow it to continue. Read more